EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic accuracy of serum protein induced by vitamin K absence (PIVKA‐II), serum a‐fetoprotein and their combination for hepatocellular carcinoma among Caucasian cirrhotic patients with diagnostic or non‐diagnostic serum a‐fetoprotein levels

Antonia Syriha, Spyridon Pantzios iD, Dionysia Mandilara, Petros Galanis, Ioanna Stathopoulou, Georgia Barla, Ioannis Elefsiniotis

Cancer Medicine · 2024

DOI: 10.1002/cam4.6825 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Antonia Syriha und 6 weiteren Autor:innen. Beteiligte Einrichtung: Academic Department of Internal Medicine-Hepatogastroenterology Unit, General and Oncology Hospital of Kifisia "Agioi Anargyroi", National and Kapodi…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Diabetes Mellitus, Protein Precursors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute for the Study of Gastrointestinal Neoplasms, Greece.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

The aim of our study was to evaluate the accuracy of serum biomarkers (AFP/PIVKA‐II) and their combination in HCC diagnosis among Caucasian cirrhotic patients.

Methods

Serum AFP/PIVKA‐II levels were evaluated in 218 cirrhotics (163 males, 118 CTP‐A, 66 ALBI‐I, 111 with varices, 63 with diabetes) with ( n = 90) or without ( n = 128) HCC. Patients with HCC were categorized to BCLC Stage 0/A ( n = 12), B ( n = 21), C ( n = 48), and D ( n = 9).

Results

The two groups were comparable for all baseline parameters except for age, platelets, and diabetes presence. Median levels of AFP (239.1 vs. 4.0 ng/mL) and PIVKA‐II (4082.7 vs. 45.8 mAU/mL) were both significantly higher in HCC group compared to controls ( p < 0.001). AUROC and cutoff value for HCC diagnosis were 88%/12.35 ng/mL (AFP) and 84.4%/677.13 mAU/mL (PIVKA‐II), whereas their combination showed better diagnostic accuracy (AUROC = 90.2%). The diagnostic accuracy of each biomarker separately was moderate or good in BCLC‐0/A/B and was excellent only for BCLC‐C patients (AFP: AUROC = 94.3%, cutoff = 12.35 ng/mL and PIVKA‐II: 91.3%, 253.51 mAU/mL) whereas their combination presented quite acceptable results in BCLC‐B (AUROC = 92.4%) and BCLC‐C (AUROC = 95.7%). Excluding HCC patients with high AFP (above 400 ng/mL), the diagnostic accuracy of each biomarker separately and their combination was moderate/good in all groups, except for their combination in BCLC‐C (AUROC = 90.5%).

Conclusions

Each biomarker separately showed acceptable accuracy for detecting HCC in cirrhotic patients and excellent for those in BCLC‐C stage. The combination of the biomarkers presented excellent results in BCLC‐B/C patients. The diagnostic accuracy of PIVKA‐II and the combination of the two biomarkers in patients expressing low/non‐diagnostic AFP levels was good in BCLC‐B and excellent in BCLC‐C patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsDiabetes MellitusProtein PrecursorsProthrombinBiomarkersMaleHumansVitamin Kalpha-FetoproteinsBlood ProteinsVitaminsLiver Cirrhosis

Stichwörter der Autor:innen

AFPHCCPIVKA-IIbiomarkerscirrhosis

Substanzen

Vitamin Kacarboxyprothrombinalpha-FetoproteinsBlood ProteinsVitaminsProtein PrecursorsProthrombinBiomarkers

Autor:innen und Institutionen

  • Academic Department of Internal Medicine-Hepatogastroenterology Unit, General and Oncology Hospital of Kifisia "Agioi Anargyroi", National and Kapodistrian University of Athens, Athens, Greece.

ORCID-Profile: Spyridon Pantzios

Förderung

  • Institute for the Study of Gastrointestinal Neoplasms, Greece

Zitieren

APA

Syriha, A., Pantzios, S., Mandilara, D., Galanis, P., Stathopoulou, I., Barla, G., & Elefsiniotis, I. (2024). Diagnostic accuracy of serum protein induced by vitamin K absence (PIVKA‐II), serum a‐fetoprotein and their combination for hepatocellular carcinoma among Caucasian cirrhotic patients with diagnostic or non‐diagnostic serum a‐fetoprotein levels. Cancer Medicine. https://doi.org/10.1002/cam4.6825

Vancouver

Syriha A, Pantzios S, Mandilara D, Galanis P, Stathopoulou I, Barla G, et al. Diagnostic accuracy of serum protein induced by vitamin K absence (PIVKA‐II), serum a‐fetoprotein and their combination for hepatocellular carcinoma among Caucasian cirrhotic patients with diagnostic or non‐diagnostic serum a‐fetoprotein levels. Cancer Medicine. 2024. doi:10.1002/cam4.6825

BibTeX
@article{Syriha2024,
  author = {Syriha, Antonia and Pantzios, Spyridon and Mandilara, Dionysia and Galanis, Petros and Stathopoulou, Ioanna and Barla, Georgia and Elefsiniotis, Ioannis},
  title = {Diagnostic accuracy of serum protein induced by vitamin K absence (PIVKA‐II), serum a‐fetoprotein and their combination for hepatocellular carcinoma among Caucasian cirrhotic patients with diagnostic or non‐diagnostic serum a‐fetoprotein levels},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.6825}
}
Kostenlos starten →